PURPOSE: COPD is the fourth leading cause of death in US. Chronic medical conditions and medications are considered important causes for Erectile Dysfunction(ED). We attempted to examine the sexual satisfaction in African American males with COPD and to determine whether there is a relationship between the degree of ED and pulmonary functions(FEV1,FVC and DLCO) and Body Mass Index(BMI).
METHODS: A Sexual Health Inventory for Men(SHIM) questionnaire was administered to male COPD patients attending the Harlem Hospital chest clinic over 2 months duration. Each patient’s SHIM score was calculated, their medical records reviewed for other comorbidities and medications. Pulmonary Function and BMI analyzed. Correlation coefficient was used to determine a relationship between the severity of ED, pulmonary functions and BMI.
RESULTS: A total of 24 patients were classified into two groups: Group A(COPD only) had 9 patients whilst Group B(COPD with other comorbidities) had 15 patients. Mean age was 67 years in Group A and 64 years in Group B. The mean SHIM scores were 11.3 and 12.1 for Groups A and B respectively. Patients in Group B were taking various antihypertensive agents either singly or in combination. The comorbidities included hypertension, coronary artery disease, heart failure and Diabetes Mellitus. The correlation coefficients between the SHIM score versus the FEV1, FVC and DLCO were 0.11, 0.10 and 0.15 respectively overall; 0.55, 0.53 and 0.76 in group A. There was no significant correlation noted with BMI.
CONCLUSION: ED is common among patients with chronic diseases including COPD. There was no appreciable correlation between the SHIM score and pulmonary functions overall. However in patients with only COPD, persistent strong correlation between the SHIM score and the DLCO (which we found in our last study) noted. There was no significant correlation noted between score versus FEV1,FVC and BMI in any groups. This suggests that the degree of the ED is related to the severity of the DLCO.
CLINICAL IMPLICATIONS: All patients with COPD and reduced DLCO should undergo screening for ED and treatments options to be offered.
DISCLOSURE: Ubair Ahmed, None.